Stock analysis, AI verdict, fundamentals & technical signals
Rating: HOLD
Price: $16.56 Analyst target: $18.00 Upside: 8.70%
Aurinia Pharmaceuticals Inc., a biopharmaceutical company, develops and markets therapies to treat various diseases with unmet medical needs in Japan and China. The company is headquartered in Victoria, Canada.
See the full interactive analysis & chart →Informational only — not investment advice.